An attempt to assess the "utility" of directional atherectomy was made using a new quantitative anglographic index. This index can be subdivided into an initial gafn component and a restenosis component. The initial gain index is the ratio between the gain in diameter during intervention and the theoreticaify achievable gafn (i.e., reference diameter). The restenosis index is the ratio between the decrease at follow-up and the initial gain during the procedure. The net result at long-term fofiow-up is characterized by the utiiity index, which is the ratio between the final gain in diameter at follow-up and what theoretically could have been achieved. Far this purpose, 30 coronary artery lesions were selected from a consecutive series of successfully dilated primary angiopiasty lesions and were matched with the initial 30 successfuiiy treated primary atherectomy lesions. Matching by location of stenosis and reference diameter resulted in 2 comparable groups with identical preprocedurai stenosis characteristics. Atherectomy resulted in an increase in minimal iuminai diameter 2 times iarger than angiopiasty (1.53 vs 0.77 mm; p <O.OOOl). However, at follow-up there was a significant decrease in minimal iuminai diameter and a significant increase in percent diameter stenosis in the groups with atherectomy and angiopiasty (1.69 f 0.66 vs 1.57 f 0.66 mm, p = not significant [NS] , and 37 f 18 vs 47 f lS%, p = NS, respectively). The decrease in minimal iuminai gain was more pronounced in the group with atherectomy than in that with angiopiasty (0.92 f 0.69 vs 0.35 f 0.51 mm; p = 0.0005). Consequently, direetionai atherecFrom the Catheterization Laboratory, Thoraxcenter, University Hospital Dijkzigt, Erasmus University Rotterdam, the Netherlands. This study was supported in part by Grant 89.241 from the Netherlands Heart Foundation, The Hague. Manuscript received May 8, 1991 ; revised manuscript received and accepted July 25, 1991. Address for reprints: Patrick W. Serruys, MD, PhD, Catheterization Laboratory, Thoraxcenter, Erasmus University Rotterdam, P.O. Box 1738,300O DR Rotterdam, the Netherlands. 1556 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 68 tomy resulted in a significantly higher initial gain ratio than did balloon angiopiasty (0.64 vs 0.41, p <O.OOOOl). At follow-up, restenosis and utility ratios were comparabfe in both groups (0.56 vs 0.62, p = NS, and 0.29 vs 0.23, p = NS, respectively). in matched groups, directional atherectomy is a very effective device wfth a substantiaify better initial result than that with balloon angiopiasty. However, it appears to be a potent stimulator of the restenosis process, because at follow-up this initial favorable resuft is lost, and the minimal iuminai diameter is comparable to that after balloon angiopiasty. Thus, the final utility of directional coronary atherectomy is not significantly different from that of conventional balloon angiopfasty.
(Am J Cardioi 1991;68:1566-1563) R estenosis after conventional balloon angioplasty remains the major limitation of this procedure.l-5 Despite extensive efforts to elucidate this phenomenon, our knowledge remains incomplete. In recent years studies have suggested that intimal hyperplasia is the major mechanism responsible for resteno&F9 and that lesion characteristics and regional flow dynamics influence this proliferative process. lo Because improved operator experience and angioplasty techniques have not caused a reduction in restenosis rates, interventional cardiologists have designed new devices aimed at debulking instead of dilating atherosclerotic plaque. Directional atherectomy is a new technique with the potential advantage of creating smooth luminal surface. However, early experience with atherectomy indicates that restenosis rates are comparable with those after conventional balloon angioplasty, although a randomized study has not been initiated11- 13 Recently it has been demonstrated that the immediate results of atherectomy are superior to those achieved by balloon angioplasty14; whether this initial advantage can be maintained during follow-up and may ultimately result in a reduction of the restenosis rate needs to be assessed. Therefore, the present study was performed to determine whether this initial favorable result obtained with athercctomy affects the incidence of restenosis.
METHODS
Patient group: From September 1989 through January 199 1, 66 patients underwent 74 atherectomy procedures. For the purpose of this study, the initial 30 consecutive patients (23 men and 7 women, mean age f standard deviation 60.2 f 10.1) who underwent an angiographically successful procedure (postprocedural diameter stenosis <50%, with tissue retrieval) of a primary lesion in a native coronary artery were selected. At the time of atherectomy, 16 patients were in New York Heart Association functional class IV, 7 in III and 7 in II. Coronary angiography showed l-vessel disease in 25 patients, 2-vessel disease in 4 and 3-vessel disease in 1. The site of obstruction was located in the left anterior descending coronary artery in 18 patients, the right coronary artery in 7 and the circumflex artery in 5.
Atherestmy procedure: After administration of local anesthesia, an 11Fr sheath was inserted in the femoral artery. All patients received 250 mg of acetylsalicylic acid and 10,000 U of heparin intravenously. Intracoronary injection of isosorbide dinitrate was performed to optimally vasodilate the vessel. After initial angiograms in multiple views were obtained, a special 11Fr guiding catheter was placed into the ostium of the coronary artery. Under fluoroscopy, the guidewire was advanced in the distal part of the artery. Then, the atherectomy device was directed over the guidewire and positioned across the stenosis. The support balloon was then inflated up to 0.5 atm, the cutter was retracted and balloon inflation pressure was increased to 2 to 3 atm. The driving motor was activated, and the rotating cutter was slowly advanced to cut and collect the protruding atherosclerotic lesion in the collecting chamber located at the tip of the catheter. After every pass, the balloon was deflated and either removed or repositioned. On average, 6.7 f 2.9 passes in multiple directions were performed across a stenosis. Atherectomy was considered successful when the residual stenosis was <50% after tissue retrieval. After atherectomy, the arterial and venous sheaths were usually left in place for 6 hours. Patients were monitored for 24 hours, and electrocardiograms and cardiac enzyme levels were obtained twice daily. Nifedipine was administered every 2 hours for 24 hours after the procedure, and the patients were administered aspirin for 1 year.
Follow-up evaluation: After successful atherectomy or angioplasty (i.e., <50% postprocedural diameter stenosis on visual inspection), patients were examined at the outpatient clinic, The follow-up coronary angiogram was obtained within 2 weeks after an exercise test. Angiography was performed earlier if symptoms occurred within 6 months. Quantitative analysis of the coronary segments was performed with the computer-based Coronary Angiography Analysis System (CAAS), previously described in detail.4~5~15~16 In essence, boundaries of a selected coronary artery segment were detected automatically from optically magnified and video-digit&d regions of interest (5 12 X 5 12 pixels) of a cineframe. The absolute diameter of the stenosis in millimeters was determined using the guiding catheter as a scaling device. Each individual catheter was measured with a micrometer and used as a scaling device. Correction for pincushion distortion was performed. The computer-estimation of the original dimension of the artery at the site of the obstruction was used to define the interpolated reference diameter. The percentage diameter and area stenosis, as well as the cross-sectional area (mm*), were then calculated.
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The length of the lesion (mm) was determined from the diameter function on the basis of curvature analysis ( Figure 1 ). Symmetry was defined as the coefficient of the left-hand distance between the reconstructed interpolated reference diameter and actual vessel contours, and the right-hand distance between the reconstructed and actual contours at the site of the obstruction. Symmetry index ranged from 0 (totally eccentric stenosis) to 1 (symmetric). The degree of coronary bend was assessed by the curvature value at the obstruction site. This parameter was computed as the average value of all individual curvature values along the centerline of the coronary segment, with curvature defined as the first derivative of the tangent as it moves along the centerline, which for a circle is equal to the reciprocal of the radius. The area between the actual and reconstructed contours at the obstruction site was defined as the area plaque (expressed in mm2). To standardize the method of analysis of the interventional and follow-up angiograms, the following measures were taken? First, the x-ray system was exactly positioned, as was noted at the time of the intervention. Second, all study frames to be analyzed were selected at enddiastole to minimize foreshortening. Third, the investigator-determined beginning and end point of a segment of a major coronary artery were identified according to the defmitions of the American Heart Association.17 Finally, Polaroid photographs were taken of the video image with the detected contours superimposed to ensure that the analysis was performed on the same coronary segments in consecutive angiograms. Patients with balloon angioplasty were enrolled in ongoing restenosis trials, and therefore, according to the protocol, systematically received intracoronary nitroglycerin before and after angioplasty, and during follow-up catheterization, where- as patients with atherectomy were less frequently administered intracoronary nitroglycerin at recatheterization. Restenosis: Two different criteria were used to defme the restenosis rate. We have found a change in minimal lumen diameter 10.72 mm to be a reliable indicator of angiographic progression of vessel narrowing.4J5J6 This value takes into account the limitations of coronary angiographic measurements and represents the long-term variability for repeat measurements of a coronary stenosis using CAAS. The second criterion for restenosis chosen was an increase in the diameter stenosis from GO% after intervention to 50% at followup. This criterion was selected because clinical practice continues to assess lesion severity by percent stenosis.
Assessment of initial gain, restanosis and utility ratio: To compare the relative efficacy of various interventional techniques, it is critical to relate the procedural outcome and changes during follow-up to the maximal achievable result. Therefore we propose the use of the aforementioned ratios in the evaluation of intracoronary interventions. Briefly, quantitative angiographic changes after intracoronary intervention may be divided in 3 stages (Figure 2) . The first or "operational stage," is characterized by the interaction of the operational device with the lesion. In becoming operational, the diameter of the device may expand (directional atherectomy, balloon, stent) or maintain its original dimensions (laser, transluminal extraction catheter, rotational ablation). During this stage, the maximal effect of the device is achieved and determines to what extent the minimal luminal diameter may be increased. The initial gain index represents the ratio between the achieved luminal and maximal achievable luminal improvements (reference diameter minus minimal lumen diameter (MLD) before intervention), and is described by the following equation: initial gain index: change in MLD at intervention/reference diameter -MLD before intervention. The initial gain index ranges from 0 (no effect) to 1 (no residual stenosis). The second stage or "restenosis stage" begins during follow-up when biological processes determine the extent of intimal hyperplasia ultimately leading to a loss of luminal gain.
The restenosis index represents the ratio of decrease in luminal diameter improvement during follow-up and the achieved changes induced by intracoronary intervention, and is described by the following equation: restenosis index: MLD after intervention -MLD followup/change in MLD at intervention. The restenosis index ranges from 0 (initial benefit intact) to 1 (initial benefit completely lost).
The utility index represents the ratio of the net gain in lumen improvement at follow-up and the maximal achievable luminal improvement, and is described by the following equation: utility index: change in MLD at intervention -change in MLD at follow-up/reference diameter -MLD before intervention. The utility index ranges from 0 (no utility) to 1 (perfect result).
Matching process: The coronary artery tree was subdivided in 15 segments according to American Heart Association guidelines,1s and the lesions were individually matched according to stenosis location and reference diameter. The principles of matching are threefold: the angiographic dimensions of matched lesions are assumed to be "identical," the observed difference between the 2 "identical" lesions must be within the range of CAAS reproducibility of 0.1 mm (1 standard deviation),5 and finally, the reference diameters of the matched vessels are selected within a range of f 0.3 mm (3 standard deviations; 99% confidence limits). To assess the immediate result of atherectomy and balloon angioplasty, 30 coronary artery lesions were selected by an independent technician (EMvS) from a consecutive series of successfully dilated balloon angioplasty lesions while complying with the selection criteria of matching. At the time of selection, the investigators were unaware of the 6-month angiographic outcome of these lesions. Matching was considered adequate if the mean difference of the reference diameter between the groups equaled 0 with standard deviation <0.3 mm.i9 Currently, the Thoraxcenter angiographic database contains quantitatively assessed stenosis data for 2,300 patients treated with either angioplasty (n = 1847) intracoronary stenting (n = 406), or directional or rotational atherectomy (n = 120).
Statistical analysis: All values are expressed as mean f 1 standard deviation. Comparisons of the severity of minimal luminal diameter, area plaque, diameter stenosis, curvature value symmetry index and length between the groups were performed using analysis of variance and the unpaired Student's t test. Differences were considered statistically significant at p <0.05.
RESULTS
Preprocedural stenosis characteristics of the matched patients are listed in Table I . Matching for stenosis location and reference diameter resulted in groups of patient with comparable severity of lesions. Matching was considered adequate because the reference diameter was equal in both groups (3.03 f 0.57 vs 3.07 f 0.55 mm; p = not significant), whereas the mean difference for this parameter between the groups was 0.0 mm (standard deviation 0.2 mm). Preprocedural minimal luminal diameter in the groups with atherectomy and angioplasty were 1.08 f 0.37 and 1.15 f 0.36 mm, respectively. The other stenosis parameters (diameter stenosis, area plaque, symmetry index and length) did not differ signilicantly, with the sole exception of curvature value, which was lower in the group tomy, and from 63 f 8 to 37 f 10% (p <O.OOl) in the that with angioplasty. At follow-up, all patients with atherectomy and angioplasty included in this study underwent 6-month control catheterization. Angiographic follow-up in the groups with atherectomy and angioplasty were 95 and 92%, respectively. Angiographic analysis at follow-up (Table II and Figure 4) showed a decrease in minimal luminal diameter in both groups (2.61 f 0.33 to 1.69 f 0.58 mm with atherectomy, 1.92 f 0.31 to 1.57 f 0.58 mm with angioplasty). Thus, the loss in minimal luminal diameter was more pronounced in the group with atherectomy than in that with angioplasty (0.92 f 0.69 vs 0.35 f 0.51 mm; p <O.OOOS). Accordingly, percent diameter stenosis increased from 19 f 9 to 37 f 18% in the group with atherectomy, and from 37 f 10 to 47 f 18% in that with angioplasty. The concomitant restenosis and utility ratios are listed in Table III . Percent restenosis (detectable hyperplasia by quantitative coronary analysis) according to the 0.72 mm decrease in minimal luminal diameter (2 times the standard deviation of the long-term variability of the mini- ma1 luminal diameter measurements using CAAS criterion) was 60% in the group with atherectomy versus 36% in that with angioplasty. When restenosis is defined by an increase in diameter stenosis 250% at follow-up, the restenosis percentages are 20 vs 16% (atherectomy vs angioplasty).
DISCUSSION
Coronary angioplasty is now an accepted form of treatment for patients with coronary artery disease. In the past, exponential growth in angioplasty has partly been the result of an increase patients returning with restenosis. Despite extensive efforts to improve catheter equipment we are still unable to effectively reduce the rate of restenosis. Because no fundamental design changes in balloon or balloon-derived catheter techniques are emerging, debulking techniques, such as directional atherectomy, have been intrcxluced to improve the angioplastic process and to presumably reduce the rate of restenosis. The potential advantages of debulking atheromatous tissue over remodeling plaque with balloon angioplasty include: minimizing smooth muscle cell injury by wall stress; eliminating smooth muscle cells and thereby reducing their proliferative potential; improving regional blood flow and rheology by inducing fewer fissures or dissections; reducing radial stretch forces, as applied with a dilating balloon; and creating larger increases in minimal luminal diameter. Indeed, recent studies have reported a larger increment in luminal improvement after atherectomy than after conventional balloon angioplasty, l4 whereas other investigators observed a low incidence of postprocedural dissections 11, 12, 14 Study design: Whether atherectomy is superior to balloon angioplasty can only be assessed by a randomized study. This type. of study would take several years, during which continuing refinements and improvements of catheter systems would take place, rendering the comparison unreliable and open to criticism. Therefore, we proposed a matching technique based on stenosis location and reference diameter to compare the results of various intracoronary interventional techniques. At present, this technique may be the best surrogate for a randomized trial when one tries to compare the shortand long-term results of atherectomy with those of conventional angioplasty. Using our matching program we selected comparable stenotic lesions with respect to baseline characteristics (minimal luminal diameter, diameter stenosis, length, area plaque and symmetry index) as assessed by quantitative angiography. This study group reflects the baseline stenosis characteristics in patients treated with atherectomy20 or balloon angioplasty. 4, 21 Immediate results: This study confirms previous reports of improved luminal gain after atherectomy compared with that after conventional angioplasty. l4 Atherectomy resulted in a twofold increase in minimal luminal diameter (1.09 f 0.37 to 2.61 f 0.33 mm) compared with that with angioplasty (1.15 f 0.36 to 1.92 f 0.31 mm). Accordingly, percent diameter stenosis decreased more dramatically after atherectomy than after angioplasty. This improvement in luminal gain with atherectomy may be due to 3 mechanisms. First, introduction of the bulky device itself causes a lumen enlargement due to the "Dotter" effect. Second, the subsequent inflation of the support balloon may lead to further enlargement by stretching of the vessel wall. Finally, excision of the plaque determines the final result.
Restenosis: Recurrence of a stenosis after intracoronary intervention may be assessed by clinical symptoms, stress testing or coronary angiography. Because symptoms and functional achievement at exercise testing have low predictive values in regard to restenosis, diagnosis of restenosis should be based on reproducible quantitative angiographic measurements using a computer-assisted technique with either automated edge detection or videodensitometry. Furthermore, the definition of restenosis is a matter of ongoing debate. It has been shown by our investigative group,4922 as well as by others3 that the determination of the severity of stenosis using percent diameter stenosis does not reflect changes after angioplasty, because the adjacent part of the dilated vessel may also be involved in the restenosis process, or the reference diameter may be simultaneously reduced. Therefore, we selected minimal luminal diameter as a parameter for the morphologic changes after atherectomy or angioplasty. Minimal luminal diameter at follow-up was 1.69 mm for the group with atherectomy compared with 1.57 mm for that with balloon angioplasty (p = not significant). These findings are similar to previously documented late follow-up studies of coronary balloon angioplasty (1.69 to 1.82 mm)4 and stenting (1.68 mm).23 Using the 250% diameter stenosis criterion, the rates of restenosis after atherectomy and angioplasty were 20 and 16%, respectively. Previous studies on restenosis after primary coronary atherectomy reported an incidence of restenosis of 20%' 1,12 using the 250% criterion. Thus, during follow-up, the initial greater gain in luminal diameter after atherectomy compared with that after balloon angioplasty is totally lost. At follow-up, the reduction in minimal luminal diameter was 0.92 mm after atherectomy compared with 0.35 mm after angioplasty (p = 0.0005). Although minimal luminal diameter changed more dramatically in the group with atherectomy than in that with angioplasty, both had equal restenosis (0.56 vs 0.62; p = not significant) and utility (0.29 vs 0.23; p = not significant) ratios, indicating that the relative changes are equal for both interventional techniques.
Animal and atherectomy studies11-13y20 have demonstrated that librointimal hyperplasia may develop in coronary arteries previously treated by balloon angioplasty or atherectomy. Pathologic findings have raised a theory that deeper vascular injury is associated with a greater intimal proliferation. Injury beyond the subintima1 level has been shown to be associated with more extensive intimal proliferation.24 These data are supported by Webster et al25 who found a greater smooth muscle proliferation after high-inflation pressure with the same balloon size when compared with that after low pressure. Furthermore, an initial follow-up study after atherectomy indicates that this process may be accelerated when deep vessel wall components such as media and adventitia are removed. 13 Additionally, atherectomy may lead to profound disrupture of the vessel wall architecture.26 Finally, the introduction of the bulkier atherectomy device may potentially lead to a greater amount of vessel wall stretching compared with that with the smaller balloon catheter system. All these influences may account for the greater cellular proliferation of the lesion treated by atherectomy.
Study limitations:
There are several limitations to this study. First, it is an uncontrolled, observational study limited to a subset of patients with successful coronary atherectomy or balloon angioplasty. This consecutive series of patients were studied by investigators unaware of the late angiographic results. Although matching for angiographic variables is a promising technique to assess the efficacy of intracoronary interventions, patient-and procedure-related variables are not included in the analysis. Second, lesion complexity was not incorporated in the analysis. This is usually defined qualitatively 27; however, an objective and quantitative description of stenosis morphology has recently been introduced. 28 Further improvement in quantitative analysis may assess lesion morphology in a continuous scale fashion rather than assigning lesions to discrete categories. This type of analysis should be incorporated in future trials studying the efficacy of various interventional techniques. Third, this study is based on early experiences with atherectomy. Careful patient selection, future design changes and improved operator experience may further improve the immediate and long-term results. Thus, controlled clinical trials are needed in the future to determine the immediate angiographic results and long-term efficacy of these interventions, as well as the benefit, if any, to particular subgroups of patients.
These studies should also address the presumed time frame for restenosis after any particular intervention.
